Approximately 2,000 new patients are diagnosed with mesothelioma every year. With over 300 consultations per year, the International Mesothelioma Program at Brigham and Women's Hospital / Harvard Medical School is the largest program of its kind in the world. Our ultimate mission is to offer state-of-the-art treatment to patients with malignant pleural mesothelioma.
The International Mesothelioma Program (IMP) encompasses a clinical program, a research program and a support program. Our clinical focus is on developing treatment strategies that can significantly extend the life of our patients. Our research focus involves a collaboration of basic, translational, and clinical research scientists whose aim is to understand the causative factors in the development of the disease and to translate these findings into improved therapy. Our dedicated mesothelioma support team provides counseling, emotional and spiritual support as well as practical help with housing and financial needs.
This page was last modified on 5/1/2014